Our offices will be closed from 23rd December 2024 to 3rd January 2025 for a two-week holiday break. Regular operations will resume on 6th January 2025, and we will follow up on any pending matters at that time. Wishing you a wonderful holiday season!
A world leader in the development and manufacturing of state-of-the-art, whole blood, point-of-care and critical care analyzers, providing the biotechnology industry with the most advanced instruments for cell culture monitoring.
About Nova Biochemical
Nova Biomedical develops, manufactures, and sells advanced technology blood testing analyzers.
Nova Biomedical is the world technology leader in the development of fast, whole blood analyzers to support the care of hospitalized and critically ill patients. Nova analyzers offer the most extensive stat test menus and deliver results in the shortest time at the lowest costs. Nova also provides handheld meter-and-strip based measuring systems for glucose, ketone, lactate, and creatinine point-of-care testing. Whether testing is performed in the central laboratory or in emergency, surgical, critical, or respiratory care areas, Nova analyzers can help to improve patient outcomes while reducing the cost of care.
With manufacturing facilities in Waltham and Billerica, Massachusetts, Belo Horizonte, Brazil and in Taipei, Taiwan, Nova is one of the 25 largest in vitro diagnostic companies in the world and the largest privately owned in vitro diagnostic company in the United States.
